Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Front Vet Sci ; 9: 1008765, 2022.
Article in English | MEDLINE | ID: mdl-36268044

ABSTRACT

Perioperative myocardial injury (PMI) is commonly caused by myocardial ischemia that develops during or after non-cardiac surgery. It occurs in 17.9% of human patients after non-cardiac surgery due to elevated high-sensitive perioperation cardiac troponin. However, PMI has not been demonstrated in cats. To investigate its occurrence, this study aimed to analyze the perioperative changes in cardiac biomarkers and clinical data, including measurement of vital signs, echocardiography, blood pressure, electrocardiogram, X-ray, and anesthetic profile, in 30 juvenile cats under neutering surgery. All cats had increased high-sensitive cardiac troponin I (hs-cTnI) postsurgery compared with presurgery. In particular, 48% of cats (14/29) showed elevated hs-cTnI over a reference range after surgery. In all groups, hs-cTnI and systolic arterial blood pressure (SAP) were significantly higher at 0 h and 18 h postoperation than at preoperation. A significant positive correlation was found between hs-cTnI and SAP at 18 h postoperation. Atrial natriuretic peptides, heart rate, and left ventricular wall thickness were markedly higher at 0 h postoperation than at preoperation; however, respiratory rate and body temperature were significantly lower at 0 h postoperation than at preoperation. Anesthetic time and hs-cTnI were significantly higher at 18 h postoperation in females than in males. Significant positive correlations were observed between hs-cTnI and anesthetic time at 18 h postoperation in females. These results indicate that postoperative hs-cTnI level can greatly increase in juvenile cats and hs-cTnI measurement at perioperation is potentially beneficial for early detection and evaluation of the presence of PMI.

2.
Open Vet J ; 12(3): 312-322, 2022.
Article in English | MEDLINE | ID: mdl-35821777

ABSTRACT

Background: Feline large granular lymphocyte lymphoma (LGLL) is a grave prognosis. However, the effectiveness of concurrent treatment with chemotherapy and activated lymphocyte therapy for feline LGLL has not been evaluated. Case Description: A 7-year-old, castrated male, domestic cat presented with gastrointestinal symptoms and an abdominal mass. A Tru-Cut biopsy of the mass revealed LGLL. The cat responded well to chemotherapy regimens of cyclophosphamide, vincristine, prednisolone, and L-asparaginase. Furthermore, activated lymphocyte therapy was added as an adjuvant treatment. The cat survived 982 days from the first presentation and experienced few adverse events. Necropsy was performed and immunohistochemistry revealed that the neoplastic lymphocytes were CD3-/CD20- cells. The final diagnosis was non-T/B LGLL. Conclusion: Minimal physical burden and a good initial response to chemotherapy might have contributed to long-term survival in the present case. Moreover, activated lymphocyte therapy could be performed safely and may be a feasible treatment for feline non-T/B LGLL.


Subject(s)
Cat Diseases , Lymphoma , Animals , Cat Diseases/drug therapy , Cats , Immunohistochemistry , Lymphocytes/pathology , Lymphoma/diagnosis , Lymphoma/veterinary , Male , Prognosis , Vincristine/therapeutic use
3.
J Vet Med Sci ; 81(11): 1643-1648, 2019 Nov 29.
Article in English | MEDLINE | ID: mdl-31554746

ABSTRACT

Pigmented viral plaque is most commonly seen in Pug dogs in association with canine papillomavirus (CPV). In the present study, nucleic acid sequence and localization of viral genes were examined in 4 cases of pigmented viral plaque in Pug dogs. The results of polymerase chain reaction and nucleic acid sequence analysis showed that the 3 cases with pigmented viral plaque were infected with CPV4, and 1 case with CPV18. In the case with CPV18-positive viral plaque, CPV18 gene was also detected in a lesion of cytokeratin-14- and P63-positive basal cell tumor that developed adjacent to a pigmented viral plaque. Moreover, CPV gene was detected in the squamous cells of pigmented viral plaques and the neoplastic cells of basal cell tumor by in situ hybridization. This is the first report of basal cell tumor associated with CPV18-infection in the dog. Infection of CPV18 may be associated with development of basal cell tumor.


Subject(s)
Dog Diseases/virology , Neoplasms, Basal Cell/veterinary , Papillomavirus Infections/veterinary , Skin Neoplasms/veterinary , Animals , DNA, Viral , Dogs , Female , Male , Neoplasms, Basal Cell/virology , Papillomaviridae/classification , Papillomaviridae/genetics , Polymerase Chain Reaction/veterinary , Sequence Analysis, DNA , Skin Diseases, Viral/veterinary , Skin Neoplasms/virology
4.
J Vet Med Sci ; 81(5): 660-666, 2019 May 11.
Article in English | MEDLINE | ID: mdl-30905908

ABSTRACT

The present paper describes Felis catus papillomavirus (FcaPV) type 5-associated cutaneous mass in a Domestic Shorthair cat. Histological examination revealed multicentric epidermal acanthosis with papillomavirus-associated cytopathic changes, which progressed to a tumor lobule with intact basement membrane. An association between FcaPV-5 and the cutaneous lesions was confirmed by detection of virus antigen and genes using immunohistochemistry, polymerase chain reaction (PCR), sequencing analysis, and in situ hybridization. Based on these findings, the lesions were diagnosed as FcaPV-5-associated viral plaques and Bowenoid in situ carcinoma (BISC). To date, this is the first reported case of FcaPV-5 infection in a cat in Japan, and the second case reported worldwide. For the first time this papillomavirus type is associated with BISC development.


Subject(s)
Bowen's Disease/veterinary , Cat Diseases/diagnosis , Papillomaviridae/isolation & purification , Animals , Antigens, Viral , Bowen's Disease/diagnosis , Cat Diseases/virology , Cats , DNA, Viral/genetics , Immunohistochemistry , Japan , Male , Papillomaviridae/genetics , Papillomaviridae/immunology , Papillomavirus Infections/diagnosis , Papillomavirus Infections/genetics , Papillomavirus Infections/veterinary , Skin Neoplasms/diagnosis , Skin Neoplasms/veterinary
5.
J Vet Med Sci ; 80(2): 190-196, 2018 Feb 09.
Article in English | MEDLINE | ID: mdl-29311492

ABSTRACT

By using a complex of DNA, polyethylenimine and chondroitin sulfate, the in vivo transfection of early secretory antigenic target-6 (ESAT-6) gene into tumor cells was found to cause significant suppression of the tumor growth. In order to apply the method in clinical cancer treatment in dogs and cats, mechanisms underlying the suppressive effects were investigated in a tumor-bearing mouse model. The transfection efficiency was only about 10%, but the transfection of ESAT-6 DNA nevertheless induced systemic immune responses against ESAT-6. By triple injection of ESAT-6 DNA at three day intervals, the tumor was significantly reduced and almost disappeared by 5 days after the start of treatment, and did not increase for more than 15 days after the final treatment. In the immunohistochemistry, a larger number of dendritic cells (DCs)/macrophages expressing ionized calcium-binding adapter molecule 1 and CD3+ T cells was observed in tumors treated with ESAT-6 DNA, and their population further increased significantly by day 5. Moreover, the amount of tumor necrosis factor, which is an apoptosis-inducing factor produced mainly by DCs/macrophages, was greater in the ESAT-6 DNA treated tumors than in controls, and increased with repeat of the treatment. These results indicate that in vivo transfection of ESAT-6 DNA into tumor cells elicits significant inhibition of tumor growth by inducing potent activity of innate immunity mediated by DCs/macrophages, which may be followed by adaptive immunity against tumor associated antigens, elicited by the costimulation with ESAT-6 antigen.


Subject(s)
Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Dendritic Cells/immunology , Immunity, Innate/immunology , Macrophages/immunology , Neoplasms, Experimental/therapy , Transfection/methods , Animals , Melanoma, Experimental , Mice , Mice, Inbred C57BL , Neoplasm Transplantation
6.
Biotechnol Lett ; 38(11): 1857-1866, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27484689

ABSTRACT

OBJECTIVES: To examine the potential of exosomes derived from the tumor cells, which had been genetically modified to express a Mycobacterium tuberculosis antigen, as a cancer vaccine aimed at overcoming the weak immunogenicity of tumor antigens. RESULTS: We transfected B16 melanoma cells with a plasmid encoding the M. tuberculosis antigen, early secretory antigenic target-6 (ESAT-6). The secreted exosomes bearing both tumor-associated antigens and the pathogenic antigen (or their epitopes) were collected. When the exosomes were injected into foot pads of mice, they significantly (p < 0.05) evoked cellular immunity against both ESAT-6, and B16 tumor cells. Intra-tumoral injection of the exosomes significantly suppressed (p < 0.001) tumor growth in syngeneic B16 tumor-bearing mice, while the exosomes derived from the non-transfected B16 cells showed no effect on tumor growth, although both exosomes should have similar tumor antigens. CONCLUSIONS: Exosomes bearing both tumor antigens and the M. tuberculosis antigen (or their epitopes) have a high potential as a candidate for cancer vaccine to overcome the immune escape by tumor cells.


Subject(s)
Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Cancer Vaccines/administration & dosage , Exosomes/metabolism , Melanoma, Experimental/drug therapy , Animals , Antigens, Bacterial/immunology , Antigens, Bacterial/metabolism , Antigens, Neoplasm/immunology , Bacterial Proteins/immunology , Bacterial Proteins/metabolism , Cancer Vaccines/genetics , Cancer Vaccines/immunology , Cell Line, Tumor , Exosomes/genetics , Exosomes/immunology , Immunotherapy , Melanoma, Experimental/genetics , Melanoma, Experimental/immunology , Mice , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/immunology , Transfection
7.
J Vet Med Sci ; 78(8): 1377-80, 2016 Sep 01.
Article in English | MEDLINE | ID: mdl-27150023

ABSTRACT

There have been limited reports on the prevalence of adverse food reactions among dogs suffering from chronic enteropathy (CE) in Japan. We examined the prevalence and histological features of food-responsive enteropathy (FRE) in a total of 32 dogs with history of CE. Fourteen of 18 cases (56.2%) diagnosed as FRE had lymphocytic-plasmacytic enteritis or eosinophilic enteritis by histopathological examination. Characteristic histopathological changes indicating FRE were not identified in 18 cases, though 4 cases did not show any abnormalities. Results collected from this study provided important information that can help to change the way dogs with CE are treated in the future.


Subject(s)
Dog Diseases/epidemiology , Food Hypersensitivity/veterinary , Intestinal Diseases/veterinary , Animal Feed , Animals , Chronic Disease , Dog Diseases/diagnosis , Dog Diseases/diet therapy , Dogs , Female , Food Hypersensitivity/diagnosis , Food Hypersensitivity/diet therapy , Food Hypersensitivity/epidemiology , Intestinal Diseases/diet therapy , Intestinal Diseases/epidemiology , Intestinal Diseases/pathology , Japan/epidemiology , Male , Prevalence
8.
J Vet Med Sci ; 77(7): 771-5, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25715707

ABSTRACT

Previously, we reported that ovarian hormones affect the immune response against E. coli isolated from the dogs affected with pyometra. In order to investigate mechanisms underlying the immune modulation, we examined the effects of ovarian hormones on the generation of dendritic cells (DCs), the most potent antigen presenting cell. DCs were differentiated from peripheral blood monocytes (PBMOs) using a cytokine cocktail. Both estrogen receptor and progesterone receptors were expressed by the PBMOs and immature DCs. When various ovarian hormones were added to the culture for the DC differentiation, progesterone significantly decreased the expression of DC maturation markers, such as CD1a, CD80 and CD86, on mature DCs. Conversely, the addition of estrogen to the cultures increased the expression of CD86, but not other maturation makers. Furthermore, DCs differentiated in the presence of progesterone did not stimulate allogeneic mononuclear cells in PB. Taken together, these results indicate that progesterone diminishes the maturation of DCs, leading to decreased immune responses against invading pathogens.


Subject(s)
Dendritic Cells/drug effects , Estrogens/pharmacology , Monocytes/physiology , Progesterone/pharmacology , Animals , Antigens, CD1/metabolism , B7-1 Antigen/metabolism , B7-2 Antigen/metabolism , Dendritic Cells/physiology , Dogs , Dose-Response Relationship, Drug , Female , Flow Cytometry/veterinary , Immunity, Cellular/drug effects , Immunity, Cellular/physiology , Receptors, Estrogen/metabolism , Receptors, Progesterone/metabolism , Reverse Transcriptase Polymerase Chain Reaction/veterinary
9.
Vet Immunol Immunopathol ; 162(1-2): 59-64, 2014 Nov 15.
Article in English | MEDLINE | ID: mdl-25239100

ABSTRACT

The existence of Th1 responses in a tumor microenvironment elicits a better prognosis for the patients. Transfection of Th1 polarizing cytokines, such as IFNγ, into tumor cells is an effective way to set up an appropriate microenvironment. Using a novel type synthetic vector composed of polyamidoamine dendrons, we transfected canine IFNγ gene into canine tumor cell lines, and examined direct and indirect effects of dendritic cells (DCs) against tumor growth in vitro. A cloned canine IFNγ gene expressed functional protein that induces maturation of DCs. When the canine IFNγ gene was transfected into canine tumor cell lines using the synthetic vector, most cells secreted canine IFNγ. Secretion of IFNγ reduced with time, but was maintained for 48h. DCs incubated with the IFNγ-transfected tumor cells exhibited greater suppressive activity and induced significantly higher cytotoxic activity against the tumor cells, relative to those incubated with untransfected tumor cells and comparable dose of IFNγ. Successful transfection of IFNγ by the synthetic vector efficiently enhanced the anti-tumor immune function of DCs, and sets up a suitable microenvironment for improvement in tumor therapy.


Subject(s)
Adenocarcinoma/veterinary , Dog Diseases/immunology , Interferon-gamma/administration & dosage , Interferon-gamma/genetics , Osteosarcoma/veterinary , Thyroid Neoplasms/veterinary , Adenocarcinoma/immunology , Adenocarcinoma/pathology , Animals , Cell Growth Processes/immunology , Cell Line, Tumor , Cytotoxicity Tests, Immunologic/veterinary , Dendritic Cells/immunology , Dog Diseases/pathology , Dogs , Female , Genetic Vectors/administration & dosage , Genetic Vectors/genetics , Interferon-gamma/immunology , Osteosarcoma/immunology , Osteosarcoma/pathology , Thyroid Neoplasms/immunology , Thyroid Neoplasms/pathology , Transfection/veterinary
10.
J Vet Med Sci ; 65(10): 1119-22, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14600352

ABSTRACT

Three canine gastrointestinal stromal tumors (GISTs) were examined. Histopathologically, the tumor mass in the jejunum (Case 1) consisted of the proliferation of epithelioid cells with abundant eosinophilic or vacuolated cytoplasm. Gangliocyte-like or multinucleated giant cells were scattered. The tumor cells exhibited neural natures mimicking human gastrointestinal autonomic nerve tumors, which were immunopositive for several neuronal markers. Another jejunal mass (Case 2) was composed by a solid proliferation of spindle-shaped cells, arranging in interlacing fascicles and occasional storiform pattern. The tumor seemed to be classified undifferentiated GISTs, that showed no apparent neural or muscular features by ultrastructural and immunohistochemical examinations. In the pyloric mass (Case 3), the spindle cells having eosinophilic processes and elongated nuclei were arranged in sheets. Immunohistochemically, the tumor cells showed muscular natures as regards alpha smooth muscle actin and desmin expression.


Subject(s)
Dog Diseases/pathology , Gastrointestinal Neoplasms/veterinary , Proto-Oncogene Proteins c-kit/genetics , Stromal Cells/pathology , Animals , Cell Differentiation , Cell Division , Dog Diseases/genetics , Dogs , Epithelial Cells/pathology , Female , Gastrointestinal Neoplasms/genetics , Gastrointestinal Neoplasms/pathology , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...